ImmuneXcite's Series B Round

ImmuneXcite raised a round of funding on January 06, 2014.

ImmuneXcite has developed a platform technology for enhancing the efficacy of therapeutic monoclonal antibodies for oncological and infectious disease targets.…

Articles about ImmuneXcite's Series B Round: